In the BioHarmony Drug Report Database

"Preview" Icon

Bictegravir

Biktarvy (bictegravir) is a small molecule pharmaceutical. Bictegravir was first approved as Biktarvy on 2018-02-07. It is used to treat HIV infections in the USA. It has been approved in Europe to treat HIV infections. Biktarvy’s patents are valid until 2036-11-08 (FDA).

 

Trade Name

 

Biktarvy
 

Common Name

 

bictegravir
 

ChEMBL ID

 

CHEMBL3989866
 

Indication

 

hiv infections
 

Drug Class

 

Antivirals: integrase inhibitors

Image (chem structure or protein)

Bictegravir structure rendering